StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 1.7 % Shares of NASDAQ EVOK opened at $1.22 on Wednesday. The company has a quick ratio […]